Delivery Order SPE2DB20D3103-SPE2DB23FP8M5

Award Date 9/25/23
Potential Completion Date 9/26/23
Potential Value $35
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a $23,700 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561542695 eszopiclone 2 mg tablets (30 count). The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The order is for a one day period of performance from July 19, 2023 through July 20, 2023. As a leading provider of pharmaceuticals and medical supplies to the Department of Defense, this order supports the DLA's stockpile of...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $67,000 to Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, to provide 4561738978 eszopiclone 2 mg tablets (30 count). The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is one day, from August 8, 2023 through August 9, 2023. No set aside designation or subcontractors were identified. The Defense...
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $18,460 to Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, to supply 4561985671 eszopiclone 1 mg tablets (30 count). The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is August 29, 2023 through August 30, 2023. As the DLA is responsible for worldwide logistics support in procurement, distribution and...
The Defense Logistics Agency awarded a $35,680 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 30-count bottles of 1 mg eszopiclone tablets. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The order is for a one-day period of performance from August 16-17, 2023. As a top supplier on the DLA's Pharmaceutical Prime Vendor contract, Amerisourcebergen will fulfill this order to supply the Defense Department's medical treatment...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $18,460 to Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, to provide 4562316198 eszopiclone 1 mg tablets (30 count) in support of the agency's pharmaceutical supply needs. Performance will occur at the prime contractor's facility located in Conshohocken, Pennsylvania under a one day period from September 26-27, 2023. No subcontractors or set aside designations were indicated. The...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $18,460 to Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, to provide 4561422744 eszopiclone 1 mg tablets (30 count) in support of the agency's pharmaceutical needs. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is July 6-7, 2023. No subcontractors or set aside designations were identified. The Defense...
The Defense Logistics Agency awarded a $36,920 delivery order to Amerisourcebergen Drug Corporation for the supply of 30-count bottles of 1 mg eszopiclone tablets. The firm fixed price order is being fulfilled from the contractor's facility in Conshohocken, Pennsylvania, with performance spanning August 25 through 28, 2023. No set aside designation or subcontracting details were provided. The order is likely supporting DLA's stockpile of pharmaceuticals for military treatment facilities and...
The Defense Logistics Agency awarded a $100,010 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561470642 eszopiclone 1 mg tablets (30 count). The prime contractor will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by July 13, 2023 to support DLA programs. Amerisourcebergen, headquartered in Conshohocken, will perform the order without involvement of major subcontractors. The funding comes from DLA's annual budget to acquire...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $7,900 to Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, to provide 4562144818 eszopiclone 2 mg tablets (30 count). The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is September 12-13, 2023. No major subcontractors or set aside designations were identified. The Defense Logistics Agency...
The Defense Logistics Agency Troop Support Medical awarded a $284,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 30,000 units of 2 mg eszopiclone tablets. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The order period of performance spans from August 21, 2023 through August 22, 2023. This delivery order was issued against an existing indefinite-delivery/indefinite-quantity contract vehicle held by...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB23FP8M5
    Delivery Order

The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $35,000 to Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, to provide 4562296377 eszopiclone 2 mg tablets (30 count). The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is September 25-26, 2023. No major subcontractors or set aside designations were identified. This order is likely in support of the DLA's stockpile of pharmaceuticals to support military treatment facilities and deploying forces worldwide.

Generated 12/25/23, 9:35 AM